Pharmacokinetics (Coursera)

Offered by Novartis,
Pharmacokinetics (Coursera)

This course begins with a review of routes of administration, ADME (absorption, distribution, metabolism, & excretion), and the use of in vivo drug concentration-time data to determine key pharmacokinetic parameters, like volume of distribution, half-life and clearance.  The course then emphasizes in vitro assays that allow rapid prediction of ADME and PK properties for evaluation of new compounds. 

Class Deals by MOOC List - Click here and see Coursera's Active Discounts, Deals, and Promo Codes.

The later stages of the course focus on how drug discovery teams study this PK/PD relationship, as well as dose size and frequency predictions which ultimately assist in selection of a compound for advancement into the clinic.  
This course is suitable for life scientists, clinicians, and individuals from fields that support drug discovery (e.g., patents, finance, licensing, etc.) interested in learning more about the pharmaceutical/biotechnology sector. Advanced undergraduate coursework or practical familiarity/working knowledge in biological sciences and organic chemistry is recommended.
This course is part of the Drug Hunting: The Science of Making New Medicines Specialization.

Syllabus

Pharmacokinetics, part 1
Welcome, by the end of the course students will be able to: Summarize the key concepts of pharmacokinetics (PK), ADME (Absorption, Distribution, Metabolism, and Excretion), volume of distribution, half-life and clearance. Differentiate between different routes of drug administration and their impact on PK parameters. Define and describe the influence of transporters, plasma protein binding (PPB) and drug-drug interactions (DDIs) on the PK of a drug molecule. Explain how PK/PD relationships are derived and their importance for defining the anticipated human dose.

Pharmacokinetics, part 2

Pharmacokinetics, part 3

Go to Class
MOOC List is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Related Courses

Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes (edX) EdX
Davidson College,DavidsonX

Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes (edX)

Drugs are biologically active compounds. Drug discovery and drug development rely on methods for measuring biological activity. The term “activity” is quite general. In practice, a substance’s biological activity can refer to how a substance affects a biological pathway, cell-level responses, safety risks, how long a substance resides within in a system, as well as a substance’s effects in an organism (called pharmacodynamics). The design of methods for measuring activity is a critical aspect of drug discovery. The design of robust and informative methods can accelerate the drug discovery and development process.

Self Paced
Self-Paced
Drugs, drug use, drug policy and health (Coursera) Coursera
University of Geneva

Drugs, drug use, drug policy and health (Coursera)

This MOOC is the first of its kind, since it addresses critical issues related to drugs from a multidisciplinary, health and human rights-based approach. Throughout the course you will cover a range of questions including what are drugs and why they controlled? What are the benefits and harms of taking drugs? How public health policies can address drug use?

Nov 9th 2026
5-12 Weeks
Drug Development (Coursera) Coursera
University of California, San Diego

Drug Development (Coursera)

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling.

Oct 26th 2026
3 Weeks
The Science Behind Anti-Doping (FutureLearn) FutureLearn
King's College London

The Science Behind Anti-Doping (FutureLearn)

Discover the life-cycle of a sample collected for anti-doping processes within sport, and the science behind it. Learn the science behind the anti-doping process with King’s College London. This fascinating course will cover the life cycle of a sample (blood and urine) collected for anti-doping purposes within sport and explain the science behind the analytical processes involved.

Self Paced
4 Weeks
Preclinical Safety: From In Vitro Assays to Human Dose Predictions (edX) EdX
Davidson College,DavidsonX

Preclinical Safety: From In Vitro Assays to Human Dose Predictions (edX)

Drugs are approved based on their “safety and efficacy”. Determining the safety of a drug occurs through studies that are largely completely separate from efficacy studies. The safety studies fall under the umbrella of preclinical safety. While a drug’s therapeutic benefit is typically narrow and well-defined, the potential safety risks of a compound can be very broad. Preclinical studies therefore search broadly in order to reveal any possible safety issues in a compound. Safety studies ultimately determine dosing limits for clinical trials as well as the final approved drug product.

Self Paced
Self-Paced
Localization Toolkit for SAP Business ByDesign (openSAP) OpenSAP
SAP

Localization Toolkit for SAP Business ByDesign (openSAP)

Join this free online course to learn how the localization toolkit for SAP Business ByDesign can help you meet your country/region-specific business needs. Many small and midsize enterprises, as well as subsidiaries of large corporations, have chosen SAP Business ByDesign to run their operations. SAP Business ByDesign supports a wide range of industry verticals and business scenarios for small and midsize enterprises.

Nov 14th 2022
4 Weeks
The Opioid Crisis in America (edX) EdX
HarvardX,Harvard University

The Opioid Crisis in America (edX)

Learn about the opioid epidemic in the United States, including information about treatment and recovery from opioid addiction. On average, 130 Americans die every day from an overdose of opioids, the class of drugs that includes heroin, hydrocodone, codeine, morphine, and fentanyl. Around 70% of all opioid overdose deaths involved a prescription opioid. Drug overdose is now the leading cause of accidental death in the United States — opioid addiction is driving this epidemic.

Self Paced
Self-Paced
Drug Commercialization (Coursera) Coursera
University of California, San Diego

Drug Commercialization (Coursera)

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success.

Nov 9th 2026
4 Weeks
Introduction to Pharmacokinetics: From ADME to PK/PD (edX) EdX
Davidson College,DavidsonX

Introduction to Pharmacokinetics: From ADME to PK/PD (edX)

A critical aspect of a drug involves how a drug is dosed and circulates throughout the body of a patient. These qualities are aspects of a drug’s pharmacokinetics or PK. Pharmacokinetics encompasses how a drug is absorbed and flows through a patient until it is ultimately eliminated. While pharmacokinetics covers drug behavior in a living organism, PK properties can often be predicted through laboratory tests for a compound’s ADME properties. ADME stands for absorption, distribution, metabolism, and excretion. The PK and ADME properties of potential drug are closely monitored throughout the discovery and early development stages of a drug campaign.

Self Paced
Self-Paced
Preclinical Safety (Coursera) Coursera
Novartis

Preclinical Safety (Coursera)

Patient safety is of paramount importance for any drug discovery program.  This course looks at some of the lessons learned which have influenced how promising molecules are currently evaluated for safety risks.  In vitro and in vivo toxicology and safety studies are discussed, why they are performed, and how the data they provide guide a safety risk assessment, including determining a therapeutic index or safety window for a drug. 

Nov 2nd 2026
3 Weeks